Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Centogene NV (CNTG)
NASDAQ:CNTG
Centogene NV (CNTG) Stock Price & Analysis
107 Followers
CNTG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.43 - $1.98
Previous Close$0.49
Volume6.94K
Average Volume (3M)58.92K
Market Cap
$13.38M
Enterprise Value$37.79M
Total Cash (Recent Filing)€35.95M
Total Debt (Recent Filing)€60.12M
Price to Earnings (P/E)N/A
Beta1.23
Next Earnings
Jun 17, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,600,000
10 Day Avg. Volume83,187
30 Day Avg. Volume58,918
Standard Deviation0.24
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.10
Price to Sales (P/S)0.28
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Centogene NV News
PremiumCompany Announcements
Centogene N.V. Faces Nasdaq Compliance Challenge
PremiumPress Releases
CENTOGENE Receives Nasdaq Non-Compliance Notice
PremiumCompany Announcements
CENTOGENE and Takeda Boost Genetic Testing for LSDs
Ownership Overview
0.00%
Insiders
0.04% Mutual Funds
8.57% Other Institutional Investors
91.39% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CNTG FAQ
What was Centogene NV’s price range in the past 12 months?
Centogene NV lowest stock price was $0.43 and its highest was $1.98 in the past 12 months.
What is Centogene NV’s market cap?
Currently, no data Available
When is Centogene NV’s upcoming earnings report date?
Centogene NV’s upcoming earnings report date is Jun 17, 2024 which is in 50 days.
How were Centogene NV’s earnings last quarter?
Currently, no data Available
Is Centogene NV overvalued?
According to Wall Street analysts Centogene NV’s price is currently Overvalued.
Does Centogene NV pay dividends?
Centogene NV does not currently pay dividends.
What is Centogene NV’s EPS estimate?
Centogene NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Centogene NV have?
Centogene NV has 27,865,751 shares outstanding.
What happened to Centogene NV’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Centogene NV?
Among the largest hedge funds holding Centogene NV’s share is Platinum Investment Management. It holds Centogene NV’s shares valued at 3M.
---
Centogene NV Stock Smart Score
Company Description
Centogene NV
Centogene NV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
---
CNTG Stock 12 Months Forecast
Average Price Target
―Technical Analysis
---